Cargando…
Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort
PARP inhibitors have shown remarkable efficacy in the clinical management of several BRCA-mutated tumors. This approach is based on the long-standing hypothesis that PARP inhibition will impair the repair of single stranded breaks, causing synthetic lethality in tumors with loss of high-fidelity dou...
Autores principales: | Principe, Daniel R., Narbutis, Matthew, Koch, Regina, Rana, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677533/ https://www.ncbi.nlm.nih.gov/pubmed/33214570 http://dx.doi.org/10.1038/s41598-020-76975-6 |
Ejemplares similares
-
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
por: Riaz, Nadeem, et al.
Publicado: (2017) -
Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients
por: Zong, Hong, et al.
Publicado: (2022) -
A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer
por: Shao, Changxia, et al.
Publicado: (2022) -
Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
por: Wang, Hai-Yun, et al.
Publicado: (2021) -
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
por: Gentles, Lucy, et al.
Publicado: (2019)